Matching-Adjusted Indirect Comparison of Long-term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
Version 2 2023-09-11, 07:56
Version 1 2023-07-23, 21:04
media
posted on 2023-09-11, 07:56 authored by Adis journals on behalf of, April W Armstrong, Sang-Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David DavidsonDavid Davidson, Viktor V ChirikovThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
